Literature DB >> 22338077

High-glycemic index carbohydrates abrogate the antiobesity effect of fish oil in mice.

Qin Hao1, Haldis H Lillefosse, Even Fjaere, Lene Secher Myrmel, Lisa K Midtbø, Ragnhild H Jarlsby, Tao Ma, Bingbing Jia, Rasmus K Petersen, Si B Sonne, André Chwalibog, Livar Frøyland, Bjørn Liaset, Karsten Kristiansen, Lise Madsen.   

Abstract

Fish oil rich in n-3 polyunsaturated fatty acids is known to attenuate diet-induced obesity and adipose tissue inflammation in rodents. Here we aimed to investigate whether different carbohydrate sources modulated the antiobesity effects of fish oil. By feeding C57BL/6J mice isocaloric high-fat diets enriched with fish oil for 6 wk, we show that increasing amounts of sucrose in the diets dose-dependently increased energy efficiency and white adipose tissue (WAT) mass. Mice receiving fructose had about 50% less WAT mass than mice fed a high fish oil diet supplemented with either glucose or sucrose, indicating that the glucose moiety of sucrose was responsible for the obesity-promoting effect of sucrose. To investigate whether the obesogenic effect of sucrose and glucose was related to stimulation of insulin secretion, we combined fish oil with high and low glycemic index (GI) starches. Mice receiving the fish oil diet containing the low-GI starch had significantly less WAT than mice fed high-GI starch. Moreover, inhibition of insulin secretion by administration of nifedipine significantly reduced WAT mass in mice fed a high-fish oil diet in combination with sucrose. Our data show that the macronutrient composition of the diet modulates the effects of fish oil. Fish oil combined with sucrose, glucose, or high-GI starch promotes obesity, and the reported anti-inflammatory actions of fish oil are abrogated. In conclusion, our data indicate that glycemic control of insulin secretion modulates metabolic effects of fish oil by demonstrating that high-GI carbohydrates attenuate the antiobesity effects of fish oil.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22338077     DOI: 10.1152/ajpendo.00524.2011

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  15 in total

1.  Variability in the cardiometabolic effects of ω-3 long-chain PUFAs: background diet, timing, and genetics.

Authors:  Beverly S Mühlhäusler
Journal:  Am J Clin Nutr       Date:  2017-04-19       Impact factor: 7.045

2.  Lipid content in hepatic and gonadal adipose tissue parallel aortic cholesterol accumulation in mice fed diets with different omega-6 PUFA to EPA plus DHA ratios.

Authors:  Shu Wang; Nirupa R Matthan; Dayong Wu; Debra B Reed; Priyanka Bapat; Xiangling Yin; Paula Grammas; Chwan-Li Shen; Alice H Lichtenstein
Journal:  Clin Nutr       Date:  2013-04-24       Impact factor: 7.324

3.  Indomethacin treatment prevents high fat diet-induced obesity and insulin resistance but not glucose intolerance in C57BL/6J mice.

Authors:  Even Fjære; Ulrike L Aune; Kristin Røen; Alison H Keenan; Tao Ma; Kamil Borkowski; David M Kristensen; Guy W Novotny; Thomas Mandrup-Poulsen; Brian D Hudson; Graeme Milligan; Yannan Xi; John W Newman; Fawaz G Haj; Bjørn Liaset; Karsten Kristiansen; Lise Madsen
Journal:  J Biol Chem       Date:  2014-04-17       Impact factor: 5.157

4.  The protein source determines the potential of high protein diets to attenuate obesity development in C57BL/6J mice.

Authors:  Ulrike Liisberg; Lene Secher Myrmel; Even Fjære; Alexander K Rønnevik; Susanne Bjelland; Kristin Røen Fauske; Jacob Bak Holm; Astrid Linde Basse; Jacob B Hansen; Bjørn Liaset; Karsten Kristiansen; Lise Madsen
Journal:  Adipocyte       Date:  2016-03-17       Impact factor: 4.534

5.  Metabolic effects of n-3 PUFA as phospholipids are superior to triglycerides in mice fed a high-fat diet: possible role of endocannabinoids.

Authors:  Martin Rossmeisl; Zuzana Macek Jilkova; Ondrej Kuda; Tomas Jelenik; Dasa Medrikova; Barbora Stankova; Björn Kristinsson; Gudmundur G Haraldsson; Harald Svensen; Iren Stoknes; Peter Sjövall; Ylva Magnusson; Michiel G J Balvers; Kitty C M Verhoeckx; Eva Tvrzicka; Morten Bryhn; Jan Kopecky
Journal:  PLoS One       Date:  2012-06-11       Impact factor: 3.240

6.  Intake of hydrolyzed casein is associated with reduced body fat accretion and enhanced phase II metabolism in obesity prone C57BL/6J mice.

Authors:  Morten Rahr Clausen; Xumin Zhang; Christian C Yde; Ditte B Ditlev; Haldis H Lillefosse; Lise Madsen; Karsten Kristiansen; Bjørn Liaset; Hanne C Bertram
Journal:  PLoS One       Date:  2015-03-04       Impact factor: 3.240

7.  Scallop protein with endogenous high taurine and glycine content prevents high-fat, high-sucrose-induced obesity and improves plasma lipid profile in male C57BL/6J mice.

Authors:  Hanne Sørup Tastesen; Alison H Keenan; Lise Madsen; Karsten Kristiansen; Bjørn Liaset
Journal:  Amino Acids       Date:  2014-07       Impact factor: 3.520

8.  A mixture of cod and scallop protein reduces adiposity and improves glucose tolerance in high-fat fed male C57BL/6J mice.

Authors:  Hanne Sørup Tastesen; Alexander Krokedal Rønnevik; Kamil Borkowski; Lise Madsen; Karsten Kristiansen; Bjørn Liaset
Journal:  PLoS One       Date:  2014-11-12       Impact factor: 3.240

9.  Of mice and men: Factors abrogating the antiobesity effect of omega-3 fatty acids.

Authors:  Lise Madsen; Karsten Kristiansen
Journal:  Adipocyte       Date:  2012-07-01       Impact factor: 4.534

10.  Urinary loss of tricarboxylic acid cycle intermediates as revealed by metabolomics studies: an underlying mechanism to reduce lipid accretion by whey protein ingestion?

Authors:  Haldis H Lillefosse; Morten R Clausen; Christian C Yde; Ditte B Ditlev; Xumin Zhang; Zhen-Yu Du; Hanne C Bertram; Lise Madsen; Karsten Kristiansen; Bjørn Liaset
Journal:  J Proteome Res       Date:  2014-04-16       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.